422 related articles for article (PubMed ID: 15994955)
1. Kinase-inactive glycogen synthase kinase 3beta promotes Wnt signaling and mammary tumorigenesis.
Farago M; Dominguez I; Landesman-Bollag E; Xu X; Rosner A; Cardiff RD; Seldin DC
Cancer Res; 2005 Jul; 65(13):5792-801. PubMed ID: 15994955
[TBL] [Abstract][Full Text] [Related]
2. Activation of different Wnt/beta-catenin signaling components in mammary epithelium induces transdifferentiation and the formation of pilar tumors.
Miyoshi K; Rosner A; Nozawa M; Byrd C; Morgan F; Landesman-Bollag E; Xu X; Seldin DC; Schmidt EV; Taketo MM; Robinson GW; Cardiff RD; Hennighausen L
Oncogene; 2002 Aug; 21(36):5548-56. PubMed ID: 12165853
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of the tumor suppressor gene phosphatase and tensin homologue partially inhibits wnt-1-induced mammary tumorigenesis.
Zhao H; Cui Y; Dupont J; Sun H; Hennighausen L; Yakar S
Cancer Res; 2005 Aug; 65(15):6864-73. PubMed ID: 16061670
[TBL] [Abstract][Full Text] [Related]
4. Activation of p53-dependent apoptosis by acute ablation of glycogen synthase kinase-3beta in colorectal cancer cells.
Ghosh JC; Altieri DC
Clin Cancer Res; 2005 Jun; 11(12):4580-8. PubMed ID: 15958644
[TBL] [Abstract][Full Text] [Related]
5. Glycogen-Synthase Kinase3beta/beta-catenin axis promotes angiogenesis through activation of vascular endothelial growth factor signaling in endothelial cells.
Skurk C; Maatz H; Rocnik E; Bialik A; Force T; Walsh K
Circ Res; 2005 Feb; 96(3):308-18. PubMed ID: 15662032
[TBL] [Abstract][Full Text] [Related]
6. Oncogenic K-ras stimulates Wnt signaling in colon cancer through inhibition of GSK-3beta.
Li J; Mizukami Y; Zhang X; Jo WS; Chung DC
Gastroenterology; 2005 Jun; 128(7):1907-18. PubMed ID: 15940626
[TBL] [Abstract][Full Text] [Related]
7. c-Jun N-terminal kinase 1 interacts with and negatively regulates Wnt/beta-catenin signaling through GSK3beta pathway.
Hu D; Fang W; Han A; Gallagher L; Davis RJ; Xiong B; Yang W
Carcinogenesis; 2008 Dec; 29(12):2317-24. PubMed ID: 18952597
[TBL] [Abstract][Full Text] [Related]
8. Adiponectin modulates the glycogen synthase kinase-3beta/beta-catenin signaling pathway and attenuates mammary tumorigenesis of MDA-MB-231 cells in nude mice.
Wang Y; Lam JB; Lam KS; Liu J; Lam MC; Hoo RL; Wu D; Cooper GJ; Xu A
Cancer Res; 2006 Dec; 66(23):11462-70. PubMed ID: 17145894
[TBL] [Abstract][Full Text] [Related]
9. Activation of the canonical Wnt/beta-catenin pathway confers growth advantages in c-Myc/E2F1 transgenic mouse model of liver cancer.
Calvisi DF; Conner EA; Ladu S; Lemmer ER; Factor VM; Thorgeirsson SS
J Hepatol; 2005 Jun; 42(6):842-9. PubMed ID: 15885355
[TBL] [Abstract][Full Text] [Related]
10. 14-3-3β regulates the proliferation of glioma cells through the GSK3β/β-catenin signaling pathway.
Gong F; Wang G; Ye J; Li T; Bai H; Wang W
Oncol Rep; 2013 Dec; 30(6):2976-82. PubMed ID: 24065186
[TBL] [Abstract][Full Text] [Related]
11. Axin negatively affects tau phosphorylation by glycogen synthase kinase 3beta.
Stoothoff WH; Bailey CD; Mi K; Lin SC; Johnson GV
J Neurochem; 2002 Nov; 83(4):904-13. PubMed ID: 12421363
[TBL] [Abstract][Full Text] [Related]
12. Lithium activates the Wnt and phosphatidylinositol 3-kinase Akt signaling pathways to promote cell survival in the absence of soluble survival factors.
Sinha D; Wang Z; Ruchalski KL; Levine JS; Krishnan S; Lieberthal W; Schwartz JH; Borkan SC
Am J Physiol Renal Physiol; 2005 Apr; 288(4):F703-13. PubMed ID: 15572521
[TBL] [Abstract][Full Text] [Related]
13. The role of glycogen synthase kinase 3beta in the transformation of epidermal cells.
Ma C; Wang J; Gao Y; Gao TW; Chen G; Bower KA; Odetallah M; Ding M; Ke Z; Luo J
Cancer Res; 2007 Aug; 67(16):7756-64. PubMed ID: 17699780
[TBL] [Abstract][Full Text] [Related]
14. Activation of the {beta}-catenin/T-cell-specific transcription factor/lymphoid enhancer factor-1 pathway by plasminogen activators in ECV304 carcinoma cells.
Maupas-Schwalm F; Robinet C; Augé N; Thiers JC; Garcia V; Cambus JP; Salvayre R; Nègre-Salvayre A
Cancer Res; 2005 Jan; 65(2):526-32. PubMed ID: 15695395
[TBL] [Abstract][Full Text] [Related]
15. Down-regulation of beta-catenin by activated p53.
Sadot E; Geiger B; Oren M; Ben-Ze'ev A
Mol Cell Biol; 2001 Oct; 21(20):6768-81. PubMed ID: 11564862
[TBL] [Abstract][Full Text] [Related]
16. [Effects of glycogen synthase kinase 3β overexpression in rat and glycogen synthase kinase 3β inhibitor SB-216763 on proliferation of hepatic oval cells].
Zhong JQ; Xie YK; Ji XK; Fu JH; Wang Y; Zhang QY; Shi HQ; Shan YF
Zhonghua Wai Ke Za Zhi; 2012 Nov; 50(11):1003-6. PubMed ID: 23302485
[TBL] [Abstract][Full Text] [Related]
17. S100A4 negatively regulates β-catenin by inducing the Egr-1-PTEN-Akt-GSK3β degradation pathway.
Yang W; Nam K; Ju JH; Lee KM; Oh S; Shin I
Cell Signal; 2014 Oct; 26(10):2096-106. PubMed ID: 24975844
[TBL] [Abstract][Full Text] [Related]
18. MUC1 oncoprotein blocks glycogen synthase kinase 3beta-mediated phosphorylation and degradation of beta-catenin.
Huang L; Chen D; Liu D; Yin L; Kharbanda S; Kufe D
Cancer Res; 2005 Nov; 65(22):10413-22. PubMed ID: 16288032
[TBL] [Abstract][Full Text] [Related]
19. Wnt/beta-catenin signaling activates growth-control genes during overload-induced skeletal muscle hypertrophy.
Armstrong DD; Esser KA
Am J Physiol Cell Physiol; 2005 Oct; 289(4):C853-9. PubMed ID: 15888552
[TBL] [Abstract][Full Text] [Related]
20. Reciprocal targeting of Hath1 and beta-catenin by Wnt glycogen synthase kinase 3beta in human colon cancer.
Tsuchiya K; Nakamura T; Okamoto R; Kanai T; Watanabe M
Gastroenterology; 2007 Jan; 132(1):208-20. PubMed ID: 17241872
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
